1-3 of 3
James Garvin
Close
Sort by
Journal Articles

Pharmacokinetics (PK) of Mycophenolate Mofetil (MMF) in Pediatric Allogeneic Stem Cell Transplant (AlloSCT) Recipients Are Associated with Significantly Higher Clearance.

Olga Militano, Kate Roache, Leslie M. Shaw, Michael Figurski, Prakash Satwani, Janet Ayello, Karen Wolownik, Sandra Foley, Ria Hawkes, Gustavo Del Toro, M. Brigid Bradley, Diane George, James Garvin, Monica Bhatia, Liz Roman, Mitchell S. Cairo
Journal: Blood
Blood (2005) 106 (11): 1823.
https://doi.org/10.1182/blood.V106.11.1823.1823
Published: 2005
Journal Articles

Preliminary Results of Reduced Intensity Allogeneic Stem Cell Transplantation (RI ALLOSCT) followed by a Dose Escalation of Targeted Consolidative Immunotherapy with Gemtuzumab Ozogamicin (GO) in Pediatric Recipients with CD33+ AML.

Elizabeth Roman, MD, Lauren Harrison, RN, Erin Cooney, CPNP, Olga Militano, Pharm, Karen Wolownik, MSN, CPNP, Ria Hawks, MSN, CPNP, Mary Brigid Bradley, MD, Gustavo Del Toro, MD, Diane George, MD, James Garvin, MD, PhD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 4510.
https://doi.org/10.1182/blood.V104.11.4510.4510
Published: 2004
Journal Articles

Reduced Intensity (RI) Allogeneic Stem Cell Transplantation (ALLOSCT) with Umbilical Cord Blood (UCB) in Pediatric Patients with Malignant and Non-Malignant Diseases.

Mary Brigid Bradley, MD, Lauren Harrison, RN, Genia Billote, RN, Erin Cooney, CPNP, Gerard Reddy, Olga Militano, Pharm, Karen Wolownik, CPNP, Ria Hawks, MSN, PNP, Diane George, MD, Gustavo Del Toro, MD, James Garvin, MD, PhD, Monica Bhatia, MD, Prakash Satwani, MD, Mitchell S. Cairo, MD
Journal: Blood
Blood (2004) 104 (11): 5167.
https://doi.org/10.1182/blood.V104.11.5167.5167
Published: 2004